Brain’s Ability to Rewire Itself is Connected to Gene Expression

New technique provides insight into the role of genes in brain plasticity and cognitive disorders.

11:06 AM

Author | Kelly Malcom

Drawing of a gene
Image by Stephanie King

From birth, the normal human brain rewires itself in response to sensory stimulation from the outside world. To put it simply, it does this by strengthening the connections between certain brain cells through a junction called a synapse. The brain's ability to change in this way is known as synaptic plasticity.

With certain cognitive disorders, like autism and Alzheimer's disease, this rewiring process is disordered. Shigeki Iwase, Ph.D., associate professor of human genetics, and his team have been attempting to understand why, using a gene called RAI1. The genetic deletion of RAI1 causes Smith Magenis Syndrome, a neurodevelopmental disorder characterized with autistic behavior and sleep disturbances.

In a new paper published in Cell Reports, the team describes how they developed a new experimental approach for monitoring gene expression across the genome in neurons while they are in the process of rewiring. "Using this method, we found that synaptic activity can change the expression of many more genes than we previously thought," says Iwase.

The new method also enabled them to discover that RAI1 plays a critical role in the gene expression underlying synaptic plasticity. In collaboration with Michael Sutton, Ph.D., professor of molecular and integrative physiology, and his team, they found evidence that neurons lacking RAI1 have impaired capability to rewire upon sensory inputs.

Says Iwase, "Our new method can be a powerful tool to determine the molecular mechanisms of how normal and diseased neuronal networks integrate environmental information, change gene expression, and ultimately generate our behavior, and identify potential drug targets for relevant brain diseases."

Paper cited: "RAI1 Regulates Activity-Dependent Nascent Transcription and Synaptic Scaling," Cell Reports. DOI: 10.1016/j.celrep.2020.108002


More Articles About:

Lab Notes Basic Science and Laboratory Research Genetic Disorders All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

drawing of gene on notebook paper
Health Lab

Modifying Writer and Eraser Enzymes Reverses Neurodevelopmental Disorders in Mice

Mouse models of two rare brain development disorders see their conditions corrected through manipulation of histone H3K4me.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has extended public comment on proposed temporary rescheduling of 7-OH and has rescheduled three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
kid at table not wanting to eat breakfast with parent blurred in background white coloring milk on table
Health Lab

Many parents face challenges getting kids to eat a healthy breakfast before school

Three-quarters of parents report at least one barrier to their child starting the day with a healthy meal on a typical school day, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
woman itching skin orange blue button down
Health Lab

A first-of-its-kind treatment for mastocytosis

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.
Microscope images of prostate cancer cells
Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.
woman with older woman at table helping on tablet
Health Lab

First person-centered measure of dementia caregiving styles improves partner, patient outcomes

First person-centered measure of dementia caregiving styles improves partner and patient outcomes.